Youli Zu Selected Research

Youli Zu Research Topics

Disease

45	Neoplasms (Cancer) 01/2024 - 03/2008
21	Lymphoma (Lymphomas) 08/2021 - 12/2009
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2022 - 11/2012
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 10/2015
6	Multiple Myeloma 01/2022 - 01/2008
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2020 - 01/2011
4	Leukemia 12/2023 - 03/2008
4	Triple Negative Breast Neoplasms 04/2022 - 01/2022
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
4	Hodgkin Disease (Hodgkin's Disease) 10/2018 - 11/2002
3	Carcinoma (Carcinomatosis) 01/2022 - 11/2016
3	COVID-19 04/2021 - 01/2021
3	Infections 04/2021 - 06/2014
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2020 - 04/2012
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2012 - 12/2007
2	Virus Diseases (Viral Diseases) 04/2021 - 01/2021
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020 - 09/2011
2	Disease Progression 03/2015 - 02/2007
2	Genetic Translocation (Chromosomal Translocation) 10/2014 - 09/2011
1	Body Weight (Weight, Body) 01/2022
1	Neuroblastoma 01/2022
1	Pneumonia (Pneumonitis) 03/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020
1	Carcinogenesis 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 12/2018
1	Hairy Cell Leukemia 09/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2017

Drug/Important Bio-Agent (IBA)

12	Rituximab (Mabthera)FDA Link 12/2016 - 11/2012
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
10	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2011
6	AntigensIBA 01/2024 - 12/2010
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2015
6	OligonucleotidesIBA 01/2021 - 01/2014
5	RNA (Ribonucleic Acid)IBA 03/2022 - 12/2010
5	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 10/2013
4	AntibodiesIBA 12/2023 - 03/2008
4	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2013
4	Nucleotide AptamersIBA 01/2022 - 12/2009
4	CytokinesIBA 12/2019 - 12/2007
4	Prednisone (Sone)FDA LinkGeneric 12/2016 - 11/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2016 - 11/2012
4	Vincristine (Oncovin)FDA LinkGeneric 12/2016 - 11/2012
3	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 10/2020
3	5-hydroxymethylcytosineIBA 01/2023 - 01/2022
3	APTIBA 08/2021 - 10/2013
3	ChemokinesIBA 12/2019 - 09/2011
3	Membrane Proteins (Integral Membrane Proteins)IBA 10/2018 - 03/2014
3	LigandsIBA 01/2018 - 05/2015
3	p38 Mitogen-Activated Protein KinasesIBA 04/2012 - 01/2008
2	Monoclonal AntibodiesIBA 01/2024 - 12/2023
2	Angiotensin-Converting Enzyme 2IBA 04/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	Small Interfering RNA (siRNA)IBA 03/2020 - 01/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 01/2019
2	Cyclin D1IBA 09/2017 - 06/2014
2	NucleotidesIBA 01/2016 - 05/2013
2	Single-Stranded DNA (DNA, Single Stranded)IBA 06/2014 - 10/2013
2	Anaplastic Lymphoma KinaseIBA 09/2011 - 01/2011
1	Complement System Proteins (Complement)IBA 01/2024
1	Caspase 9IBA 01/2024
1	HLA-A*02:01 antigenIBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	Cell Surface ReceptorsIBA 12/2023
1	CholesterolIBA 12/2023
1	histone H3 trimethyl Lys4IBA 01/2023
1	Gemcitabine FDA Link 04/2022
1	Dendrimers (Dendrons)IBA 04/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	carfilzomibIBA 01/2022
1	EnzymesIBA 03/2021
1	Oxygen (Dioxygen)IBA 03/2021
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021
1	Aligeron (AS 2)IBA 01/2021
1	IsotopesIBA 01/2021
1	Epithelial Cell Adhesion MoleculeIBA 01/2021
1	selinexorIBA 11/2020
1	Immunoglobulin G (IgG)IBA 10/2020
1	Protamines (Protamine Sulfate)FDA Link 03/2020
1	p80(NPM-ALK) proteinIBA 01/2020
1	NivolumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2018
1	liposomal doxorubicin (Doxil)FDA Link 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	Conditioned Culture MediaIBA 01/2018
1	Liposomes (Liposome)IBA 01/2018
1	Annexin A1IBA 09/2017
1	Sickle HemoglobinIBA 01/2017

Therapy/Procedure

23	Therapeutics 04/2022 - 12/2011
12	Drug Therapy (Chemotherapy) 12/2023 - 01/2016
7	Immunotherapy 01/2024 - 11/2013
3	Precision Medicine 12/2018 - 05/2015
1	Artificial Respiration (Mechanical Ventilation) 03/2021
1	Biological Therapy 11/2020